pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Atovaquone
drug
save

atovaquone

Marketedupdated 3mo ago
by Abhai Inc
Approved
community read0 votes

🐶 often sniffed alongside

top 6
  • tagApproval60 co-mentions · 30 sources
  • drugMALARONE PEDIATRIC47 co-mentions · 30 sources
  • drugMEPRON43 co-mentions · 30 sources
  • tagSmall Molecule30 co-mentions · 30 sources
  • drugatovaquone LA30 co-mentions · 30 sources
  • companyGlaxoSmithKline LLC13 co-mentions · 13 sources

all catalysts(30)

approval · 30
Feb 8, 1995
approval
32y ago
MEPRON (ATOVAQUONE) — FDA approval
atovaquone
→
Apr 28, 1995
approval
31y ago
MEPRON (ATOVAQUONE) — FDA approval
atovaquone
→
May 2, 1997
approval
29y ago
MEPRON (ATOVAQUONE) — FDA approval
atovaquone
→
Aug 12, 1997
approval
29y ago
MEPRON (ATOVAQUONE) — FDA approval
atovaquone
→
Sep 14, 1998
approval
28y ago
MEPRON (ATOVAQUONE) — FDA approval
atovaquone
→
Jan 5, 1999
approval
28y ago
MEPRON (ATOVAQUONE) — FDA approval
atovaquone
→
Jul 14, 2000
approval
26y ago
MALARONE PEDIATRIC (ATOVAQUONE) — FDA approval
atovaquone
→
Feb 28, 2002
approval
24y ago
MALARONE PEDIATRIC (ATOVAQUONE) — FDA approval
atovaquone
→
May 13, 2002
approval
24y ago
MALARONE PEDIATRIC (ATOVAQUONE) — FDA approval
atovaquone
→
Aug 2, 2002
approval
24y ago
MALARONE PEDIATRIC (ATOVAQUONE) — FDA approval
atovaquone
→
May 9, 2003
approval
23y ago
MALARONE PEDIATRIC (ATOVAQUONE) — FDA approval
atovaquone
→
Dec 2, 2003
approval
23y ago
MALARONE PEDIATRIC (ATOVAQUONE) — FDA approval
atovaquone
→
Sep 3, 2004
approval
22y ago
MALARONE PEDIATRIC (ATOVAQUONE) — FDA approval
atovaquone
→
Nov 24, 2004
approval
22y ago
MALARONE PEDIATRIC (ATOVAQUONE) — FDA approval
atovaquone
→
Feb 27, 2005
approval
21y ago
MALARONE PEDIATRIC (ATOVAQUONE) — FDA approval
atovaquone
→
Feb 27, 2005
approval
21y ago
MALARONE PEDIATRIC (ATOVAQUONE) — FDA approval
atovaquone
→
Dec 4, 2007
approval
19y ago
MALARONE PEDIATRIC (ATOVAQUONE) — FDA approval
atovaquone
→
May 7, 2008
approval
18y ago
MEPRON (ATOVAQUONE) — FDA approval
atovaquone
→
May 7, 2008
approval
18y ago
MALARONE PEDIATRIC (ATOVAQUONE) — FDA approval
atovaquone
→
Dec 18, 2008
approval
18y ago
MALARONE PEDIATRIC (ATOVAQUONE) — FDA approval
atovaquone
→
Sep 2, 2009
approval
17y ago
MALARONE PEDIATRIC (ATOVAQUONE) — FDA approval
atovaquone
→
Feb 27, 2013
approval
13y ago
MALARONE PEDIATRIC (ATOVAQUONE) — FDA approval
atovaquone
→
Mar 1, 2013
approval
13y ago
MEPRON (ATOVAQUONE) — FDA approval
atovaquone
→
Jun 4, 2015
approval
11y ago
MEPRON (ATOVAQUONE) — FDA approval
atovaquone
→
Oct 15, 2017
approval
9y ago
MEPRON (ATOVAQUONE) — FDA approval
atovaquone
→
Feb 22, 2019
approval
7y ago
MEPRON (ATOVAQUONE) — FDA approval
atovaquone
→
Feb 22, 2019
approval
7y ago
MALARONE PEDIATRIC (ATOVAQUONE) — FDA approval
atovaquone
→
Jul 18, 2019
approval
7y ago
MEPRON (ATOVAQUONE) — FDA approval
atovaquone
→
Mar 20, 2026
approval
5mo ago
MEPRON (ATOVAQUONE) — FDA approval
atovaquone
→
Mar 23, 2026
approval
5mo ago
MALARONE PEDIATRIC (ATOVAQUONE) — FDA approval
atovaquone
→
view all 30 catalysts →

Trials studying atovaquone

  • phase2Efficacy, Safety, and PK of M5717 in Combination With Pyronaridine as Chemoprevention in Adults and Adolescents With Asymptomatic Plasmodium Falciparum Infection (CAPTURE-2)completedn=192
  • phase1A Study to Evaluate Antimalarial Activity and Safety of MK-7602 in Healthy Adults (MK-7602-003)completedn=16

News(0)

no news has mentioned this drug yet

brand
Atovaquone
generic
atovaquone
indication
Pneumocystis Pneumonia (Pneumocystosis/Pneumocystis jiroveci Pneumonia)
phase
marketed
Data sources
openFDA · ClinicalTrials.gov
last refreshed 37m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?